Cargando…
Assay development and inhibition of the Mt-DprE2 essential reductase from Mycobacterium tuberculosis
DprE2 is an essential enzyme in the synthesis of decaprenylphosphoryl-β-d-arabinofuranose (DPA) and subsequently arabinogalactan, and is a significant new drug target for M. tuberculosis . Two compounds from the GSK-177 box set, GSK301A and GSK032A, were identified through Mt-DprE2-target overexpres...
Autores principales: | Batt, Sarah M., Toth, Szilvi, Rodriguez, Beatriz, Abrahams, Katherine A., Veerapen, Natacha, Chiodarelli, Giacomo, Cox, Liam R., Moynihan, Patrick J., Lelievre, Joel, Fütterer, Klaus, Besra, Gurdyal S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Microbiology Society
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9993113/ https://www.ncbi.nlm.nih.gov/pubmed/36748627 http://dx.doi.org/10.1099/mic.0.001288 |
Ejemplares similares
-
DprE2 is a molecular target of the anti-tubercular nitroimidazole compounds pretomanid and delamanid
por: Abrahams, Katherine A., et al.
Publicado: (2023) -
Novel insight into the reaction of nitro, nitroso and hydroxylamino benzothiazinones and of benzoxacinones with Mycobacterium tuberculosis DprE1
por: Richter, Adrian, et al.
Publicado: (2018) -
Inoculum-dependent bactericidal activity of a Mycobacterium tuberculosis MmpL3 inhibitor
por: Berube, Bryan, et al.
Publicado: (2023) -
Construction and evaluation of a bioluminescent Pseudomonas aeruginosa reporter for use in preservative efficacy testing
por: Rushton, Laura, et al.
Publicado: (2021) -
Impact of growth media and pressure on the diversity and antimicrobial activity of isolates from two species of hexactinellid sponge
por: Koch, Matthew J., et al.
Publicado: (2021)